Manufacturers/ViiV Healthcare Company

ViiV Healthcare Company

13 drugs in NADAC|0 Generic,13 Brand

View Recalls (1)

Total Drugs

0G / 13B

Avg Price / Unit

$60.6468

$0.45 – $156.87

Avg 7d Change

0.00%

Across 0 drugs with changes

7d Activity

13 flat

of 13 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Drug Portfolio

13 drugs total, 13 shown

Drug ↕	NDC	Price	7d Change ↕	Class	Market Outlier	Therapeutic Class
RUKOBIA ER 600 MG TABLET fostemsavir tromethamine	49702025018	$156.8667 per EA	—	Brand	—	—
TRIUMEQ 600-50-300 MG TABLET abacavir sulfate, dolutegravir sodium, lamivudine	49702023113	$130.0048 per EA	—	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
JULUCA 50-25 MG TABLET dolutegravir sodium and rilpivirine hydrochloride	49702024213	$121.9492 per EA	—	Brand	—	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor
DOVATO 50-300 MG TABLET dolutegravir sodium and lamivudine	49702024613	$105.2874 per EA	—	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
DOVATO 50-300 MG TABLET dolutegravir sodium and lamivudine	49702024633	$105.2874 per EA	—	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
TIVICAY 50 MG TABLET dolutegravir sodium	49702022813	$77.6627 per EA	—	Brand	—	Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor
SELZENTRY 300 MG TABLET maraviroc	49702022418	$28.0198 per EA	—	Brand	High Outlier	CCR5 Co-receptor Antagonist
SELZENTRY 150 MG TABLET maraviroc	49702022318	$27.9961 per EA	—	Brand	High Outlier	CCR5 Co-receptor Antagonist
COMBIVIR TABLET lamivudine and zidovudine	49702020218	$14.3948 per EA	—	Brand	High Outlier	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EPIVIR 300 MG TABLET lamivudine	49702020413	$13.2940 per EA	—	Brand	High Outlier	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EPIVIR 150 MG TABLET lamivudine	49702020318	$6.6144 per EA	—	Brand	High Outlier	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
ZIAGEN 20 MG/ML SOLUTION abacavir sulfate	49702022248	$0.5865 per ML	—	Brand	—	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EPIVIR 10 MG/ML ORAL SOLN lamivudine	49702020548	$0.4452 per ML	—	Brand	High Outlier	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

FDA Recalls (1)

Recalls matched by company name. Verify current status with FDA.

D-1185-2014 →

Terminated

Class III

Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 27709; by: GlaxoSmithKline, Research Triangle Park, NC 27709. Made in Japan. NDC 49702-228-13

Cross Contamination with Other Products: Product contains Promacta (eltrombopag).

Initiated: 2/11/2014